Generic Name |
imatinib + Selinexor | |
---|---|---|
IND |
||
Brand Name (US) |
||
Manufacturer |
||
Drug Type |
KIT + Nuclear export inhibitor | |
Delivery |
Oral | |
Approval Status |
||
Indications |
||
Overall Strategy |
GIST cell based | |
Strategy |
Inhibit KIT and arrest cell cycle | |
Drug Category |
KIT + Nuclear export inhibitor |
Links |
|
Trials of this drug |
|
|
Selinexor in Combination With Imatinib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors. (SeliGIST) |
Trial results |